Trial intelligence / Profile preview

Mechanism of Dymista Efficacy in Seasonal Allergic Rhinitis

NCT02402465Phase 4Completed

Sponsor
University of Chicago
Start
Feb 2015
Primary completion
Mar 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by University of Chicago. Started Feb 2015; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT02402465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02402465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call